Gm. Segal et al., REPRESSION OF FANCONI-ANEMIA GENE (FACC) EXPRESSION INHIBITS GROWTH OF HEMATOPOIETIC PROGENITOR CELLS, The Journal of clinical investigation, 94(2), 1994, pp. 846-852
Bone marrow failure is a consistent feature of Fanconi anemia (FA) but
it is not known whether the bone marrow failure is a direct and speci
fic result of the inherited mutation or a consequence of accumulated s
tem cell losses resulting from nonspecific DNA damage. We tested the h
ypothesis that the protein encoded by the FA group C complementing gen
e (FACC) plays a regulatory role in hematopoiesis. We exposed normal h
uman lymphocytes, bone marrow cells, endothelial cells, and fibroblast
s to an antisense oligodeoxynucleotide (ODN) complementary to bases -4
to +14 of FACC mRNA. The mitomycin C assay demonstrated that the anti
sense ODN, but not missense or sense ODNs, repressed FACC gene express
ion in lymphocytes. Treatment with the antisense ODN substantially red
uced, in a sequence-specific fashion, cytoplasmic levels of FACC mRNA
in bone marrow cells and lymphocytes. Escalating doses of antisense OD
N increasingly inhibited clonal growth of erythroid and granulocyte-ma
crophage progenitor cells but did not inhibit growth of fibroblasts or
endothelial cells. The antisense ODN did not inhibit growth factor ge
ne expression by low density bone marrow cells or marrow-derived fibro
blasts. We conclude that, while the FACC gene product plays a role in
defining cellular tolerance to cross-linking agents, it also functions
to regulate growth, differentiation, and/or survival of normal hemato
poietic progenitor cells.